A Comparative Clinical Study Of Atasi Upanaha Sweda (Flax Seed Hot Poultices) With And without internal administration of kanchanara guggulu (herbal tablet) in sirajagranthi w s r to varicose veins
Phase 2
- Conditions
- Health Condition 1: I831- Varicose veins of lower extremities with inflammation
- Registration Number
- CTRI/2019/01/016835
- Lead Sponsor
- Dr Akhil M
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients aged between 20 to 70 years as this condition is commonly noted in these age group irrespective of sex caste and religion will be selected
Patients who are fit for upanaha sweda
Patients suffering from primary varicose vein
Exclusion Criteria
Patients with systemic diseases interfering with the treatment
Congenital varicose veins
Swedana anarhas
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Atasi Upanaha Sweda's efficacy in treating I831 varicose veins with inflammation?
How does Kanchanara Guggulu compare to standard-of-care treatments for lower extremity varicose veins in clinical trials?
Are there specific biomarkers that predict response to Atasi Upanaha Sweda or Kanchanara Guggulu in venous disorders?
What adverse events are associated with Ayurvedic therapies like Atasi Upanaha Sweda and Kanchanara Guggulu for varicose veins?
What combination approaches involving herbal formulations and conventional treatments show promise for chronic venous insufficiency?